The application of discriminant analysis and Machine Learning methods as tools to identify and classify compounds with potential as transdermal enhancers.
暂无分享,去创建一个
G P Moss | A J Shah | R G Adams | N Davey | S C Wilkinson | W J Pugh | Y Sun | N. Davey | Yi Sun | G. Moss | S. Wilkinson | R. Adams | W. Pugh | Alpa Shah
[1] Majella E Lane,et al. Skin penetration enhancers. , 2013, International journal of pharmaceutics.
[2] M T D Cronin,et al. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.
[3] J Hadgraft,et al. Epidermal permeability-penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. , 2000, International journal of pharmaceutics.
[4] M. Player,et al. Transdermal and dermal enhancing activity of pyrrolidinones in hairless mouse skin , 1997 .
[5] G P Moss,et al. Discriminant analysis as a tool to identify compounds with potential as transdermal enhancers , 2005, The Journal of pharmacy and pharmacology.
[6] Carl E. Rasmussen,et al. Gaussian processes for machine learning , 2005, Adaptive computation and machine learning.
[7] Neil Davey,et al. The application of feature selection to the development of Gaussian process models for percutaneous absorption , 2010, The Journal of pharmacy and pharmacology.
[8] Alexander J. Smola,et al. Learning with Kernels: support vector machines, regularization, optimization, and beyond , 2001, Adaptive computation and machine learning series.
[9] M. Player,et al. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. II: (Thio) amides , 1993 .
[10] J. Hadgraft,et al. Mechanism of action of Azone as a percutaneous penetration enhancer: Lipid bilayer fluidity and transition temperature effects , 1988 .
[11] Michael H. Abraham,et al. Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes , 2010 .
[12] P Buchwald,et al. A simple, predictive, structure‐based skin permeability model , 2001, The Journal of pharmacy and pharmacology.
[13] J. Platts,et al. Hydrogen bond structural group constants. , 2001, The Journal of organic chemistry.
[14] Mark T D Cronin,et al. Quantitative structure-permeability relationships for percutaneous absorption: re-analysis of steroid data. , 2002, International journal of pharmaceutics.
[15] Vipin Kumar,et al. Evaluating boosting algorithms to classify rare classes: comparison and improvements , 2001, Proceedings 2001 IEEE International Conference on Data Mining.
[16] Neil Davey,et al. The application of stochastic machine learning methods in the prediction of skin penetration , 2011, Appl. Soft Comput..
[17] D. W. Van Krevelen,et al. Cohesive Properties and Solubility , 2009 .
[18] K. Larsson,et al. On the effect of urea on human epidermis. , 1974, Dermatologica.
[19] Nitesh V. Chawla,et al. SMOTE: Synthetic Minority Over-sampling Technique , 2002, J. Artif. Intell. Res..
[20] R. Latour,et al. Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine)hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modeling. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[21] J E Riviere,et al. Modelling the effect of mixture components on permeation through skin. , 2010, International journal of pharmaceutics.
[22] Michael H. Abraham,et al. Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters, .pi.*, .alpha., and .beta., and some methods for simplifying the generalized solvatochromic equation , 1983 .
[23] M. Cronin,et al. Pitfalls in QSAR , 2003 .
[24] M. Player,et al. Synthesis and investigation of urea compounds as transdermal penetration enhancers , 1998 .
[25] S. Singh,et al. Transdermal drug delivery by passive diffusion and iontophoresis: A review , 1993, Medicinal research reviews.
[26] Neil Davey,et al. The application of Gaussian processes in the prediction of percutaneous absorption , 2009, ESANN.
[27] G P Moss,et al. Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[28] Taravat Ghafourian,et al. The effect of penetration enhancers on drug delivery through skin: a QSAR study. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[29] Michael S. Roberts,et al. Simple Rules Defining the Potential of Compounds for Transdermal Delivery or Toxicity , 2004, Pharmaceutical Research.
[30] Christopher M. Bishop,et al. Neural networks for pattern recognition , 1995 .
[31] J. Hadgraft,et al. Mixed monolayers of dipalmitoylphosphatidylcholine with Azone or oleic acid at the air-water interface , 1990 .
[32] M D Barratt,et al. Quantitative structure-activity relationships for skin permeability. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.
[33] Russell O. Potts,et al. A Predictive Algorithm for Skin Permeability: The Effects of Molecular Size and Hydrogen Bond Activity , 1995, Pharmaceutical Research.
[34] Russell O. Potts,et al. Predicting Skin Permeability , 1992, Pharmaceutical Research.
[35] Michael H. Abraham,et al. LINEAR SOLVATION ENERGY RELATIONSHIPS. 23. A COMPREHENSIVE COLLECTION OF THE SOLVATOCHROMIC PARAMETERS, Π*, α, AND β, AND SOME METHODS FOR SIMPLIFYING THE GENERALIZED SOLVATOCHROMIC EQUATION , 1984 .
[36] H. Maibach,et al. Classification of percutaneous penetration enhancers: A conceptional diagram , 1990, The Journal of pharmacy and pharmacology.
[37] R. F. Fedors,et al. A method for estimating both the solubility parameters and molar volumes of liquids , 1974 .
[38] J. Fletcher,et al. Factors affecting the permeability of skin. The relation between in vivo and in vitro observations. , 1978, Current problems in dermatology.
[39] L. Strekowski,,et al. Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. , 1999, International journal of pharmaceutics.
[40] J. Fletcher,et al. Factors Affecting the Permeability of Skin , 1978 .
[41] M. Player,et al. In vitro evaluation of azone analogs as dermal penetration enhancers: V. Miscellaneous compounds , 1998 .
[42] Fumiyoshi Yamashita,et al. Prediction of human skin permeability using a combination of molecular orbital calculations and artificial neural network. , 2002, Biological & pharmaceutical bulletin.
[43] Taravat Ghafourian,et al. Validated models for predicting skin penetration from different vehicles. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[44] Asbill,et al. Percutaneous penetration enhancers: local versus transdermal activity. , 2000, Pharmaceutical science & technology today.
[45] M. Abraham,et al. Algorithms for Skin Permeability Using Hydrogen Bond Descriptors: the Problem of Steroids * , 1997, The Journal of pharmacy and pharmacology.
[46] Jonathan Hadgraft,et al. Ab initio prediction of human skin permeability coefficients , 1994 .
[47] A. Nokhodchi,et al. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. , 2003, International journal of pharmaceutics.
[48] Fredric C. Gey,et al. The relationship between recall and precision , 1994 .